Security key
640671400
NEPHROS INC - Common Stock - $0.001 par value (NEPH)
CUSIP: 640671400
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock - $0.001 par value
- Shares outstanding
- 10,630,964
- Total 13F shares
- 5,015,032
- Share change
- +162,720
- Total reported value
- $23,721,183
- Price per share
- $4.73
- Number of holders
- 23
- Value change
- +$770,357
- Number of buys
- 8
- Number of sells
- 9
Report period
Q3 2025
Institutions
23
Top holders
10
NEPH full security history
Newer quarter: Q4 2025
Previous quarter: Q2 2025
NEPHROS INC SEC filings
NEPHROS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 640671400
Recent filing periods:
Top shareholders of NEPH - NEPHROS INC - Common Stock - $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Topline Capital Management, LLC |
13D/G
13F
|
Company |
5.6%
|
595,334
|
$2,815,930 | $0 | 04 Aug 2025 | |
| WEXFORD CAPITAL LP |
13F
3/4/5
|
Company · 10%+ Owner |
34%
|
3,608,081
|
$14,757,054 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3%
|
323,443
|
$1,322,882 | — | 30 Jun 2025 | |
| BARD ASSOCIATES INC |
13F
|
Company |
1.2%
|
131,121
|
$536,285 | — | 30 Jun 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.88%
|
93,187
|
$381,211 | — | 30 Jun 2025 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.53%
|
55,876
|
$228,533 | — | 30 Jun 2025 | |
| BLAIR WILLIAM & CO/IL |
13F
|
Company |
0.34%
|
36,249
|
$148,258 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.28%
|
29,425
|
$120,348 | — | 30 Jun 2025 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.23%
|
24,822
|
$101,522 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.15%
|
15,698
|
$64,205 | — | 30 Jun 2025 | |
| ELKHORN PARTNERS LIMITED PARTNERSHIP |
13F
|
Company |
0.14%
|
14,500
|
$59,305 | — | 30 Jun 2025 | |
| Mesirow Financial Investment Management, Inc. |
13F
|
Company |
0.13%
|
13,800
|
$56,442 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.11%
|
11,890
|
$48,630 | — | 30 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.1%
|
10,900
|
$44,581 | — | 30 Jun 2025 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
2,523
|
$10,319 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.02%
|
1,915
|
$7,832 | — | 30 Jun 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,105
|
$4,519 | — | 30 Jun 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
175
|
$715 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
122
|
$499 | — | 30 Jun 2025 | |
| JONES FINANCIAL COMPANIES LLLP |
13F
|
Company |
0%
|
31
|
$120 | — | 30 Jun 2025 | |
| Daron Evans |
3/4/5
|
CEO Specialty Renal Products |
—
mixed-class rows
|
179,718
mixed-class rows
|
$351,795 | — | 24 May 2021 | |
| Andrew Astor Power |
3/4/5
|
President, CEO & CFO, Director |
—
mixed-class rows
|
131,385
mixed-class rows
|
$204,342 | — | 05 Mar 2022 | |
| Alisa Lask |
3/4/5
|
Director |
—
mixed-class rows
|
55,679
mixed-class rows
|
$109,167 | — | 01 Jan 2025 | |
| Tom Gwydir Power |
3/4/5
|
Director |
—
mixed-class rows
|
50,306
mixed-class rows
|
$95,210 | — | 05 Jan 2023 | |
| Wesley S. Lobo |
3/4/5
|
Chief Marketing Officer |
—
mixed-class rows
|
206,714
mixed-class rows
|
$77,461 | — | 16 Feb 2022 | |
| Joseph Michael Harris |
3/4/5
|
Director |
—
mixed-class rows
|
24,743
mixed-class rows
|
$39,719 | — | 01 Jan 2025 |
Institutional Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q3 2025
As of 30 Sep 2025,
NEPHROS INC - Common Stock - $0.001 par value (NEPH) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,015,032 shares.
The largest 10 holders included
WEXFORD CAPITAL LP, Topline Capital Management, LLC, VANGUARD GROUP INC, BARD ASSOCIATES INC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, HighTower Advisors, LLC, BLAIR WILLIAM & CO/IL, ESSEX INVESTMENT MANAGEMENT CO LLC, and GOLDMAN SACHS GROUP INC.
This page lists
23
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
20
Q3 2025 holders
23
Holder diff
3
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.